# Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

> **NCT06277037** · — · RECRUITING · sponsor: **Arbutus Biopharma Corporation** · enrollment: 50 (estimated)

## Conditions studied

- Long Term Follow-up

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT06277037
- **Lead sponsor:** Arbutus Biopharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2029-08-30
- **Final completion:** 2029-10-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06277037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06277037, "Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06277037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*